![David Koos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Koos
Directeur Général chez
REGEN BIOPHARMA, INC.
Fortune : 4 959 $ au 30/06/2026
Profil
David Raymond Koos was the founder of Entest Group, Inc., founded in 2008, where the titles held included Chairman, President, CEO, CFO & Secretary from 2009 to 2018.
Current jobs include Chairman, President, CEO, CFO & Secretary at Regen Biopharma, Inc. since 2012; Chairman, President, CEO, Secretary & Treasurer at Kcl Therapeutics, Inc. since 2021; Chairman & Chief Executive Officer at BST Partners, Inc. since 2018; President & Managing Director at Venture Bridge, Inc. since 2001; President, Managing Director & Director at Cell Source Research, Inc. since 2003; Trustee at BMXP Holdings Shareholders Business Trust; and Trustee at AFN Trust.
Former jobs include President & Chief Executive Officer at Tasco Holdings International, Inc. in 2006; Chairman, Chief Executive Officer, CFO & Secretary at Frezer, Inc. from 2005 to 2007; President, CEO, CFO, Secretary & CAO at JB Clothing Corp.
in 2009; Chairman, CEO & Acting Chief Financial Officer at BMXP Holdings, Inc. from 2004 to 2008; Chairman, President, CEO, CFO & Secretary at Rivulet Media, Inc. from 2006 to 2019; Chairman & Chief Executive Officer at Freedom Environmental Services, Inc.; Chairman & Chief Executive Officer at BEFUT International Co. Ltd.; Chairman, President, CEO, CFO & Secretary at Entest BioMedical, Inc.; Chairman & Chief Executive Officer at Zander Therapeutics, Inc. from 2017 to 2020; Chairman, President, CEO, Secretary & Treasurer at SYBLEU, Inc. from 2020 to 2022; Chairman & Chief Executive Officer at BST Partners, Inc. (Wyoming); and Chairman, Chief Financial Officer & Secretary at Cell Bio-Systems, Inc. in 2003.
Education includes a graduate degree from the University of California, Riverside in 1983 and a doctorate from Atlantic International University in 2003.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/11/2025 | 826 576 ( 0,53% ) | 4 959 $ | 30/06/2026 | |
| 10/11/2025 | 334 ( 100% ) | - $ | 30/06/2026 | |
REGEN BIOPHARMA, INC. 26,13% | 10/11/2025 | 7 667 ( 26,13% ) | - $ | 30/06/2026 |
| 10/11/2025 | 27 436 799 ( 5,36% ) | - $ | 30/06/2026 | |
| 10/11/2025 | 15 007 ( 100% ) | - $ | 30/06/2026 |
Postes actifs de David Koos
| Sociétés | Poste | Début |
|---|---|---|
| REGEN BIOPHARMA, INC. | Directeur Général | 24/04/2012 |
BST Partners, Inc. | Directeur Général | 30/11/2018 |
Kcl Therapeutics, Inc. | Directeur Général | 23/03/2021 |
AFN Trust | Directeur/Membre du Conseil | - |
BMXP Holdings Shareholders Business Trust | Directeur/Membre du Conseil | - |
Cell Source Research, Inc. | Directeur Général | 24/03/2003 |
Venture Bridge, Inc. | Directeur Général | 21/11/2001 |
Anciens postes connus de David Koos
| Sociétés | Poste | Fin |
|---|---|---|
| SYBLEU INC. | Directeur Général | 13/12/2022 |
Zander Therapeutics, Inc.
 Zander Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for cancer | Directeur Général | 22/01/2020 |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de David Koos
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Cell Bio-Systems, Inc.
 Cell Bio-Systems, Inc. Medical SpecialtiesHealth Technology Manufactures distribute patented technologies for plastic and cosmetic surgery, biopsy, orthopedic surgery and other living tissue markets | Health Technology |
Tasco Holdings International, Inc.
 Tasco Holdings International, Inc. Financial ConglomeratesFinance Development stage company | Finance |
Frezer, Inc.
 Frezer, Inc. Medical SpecialtiesHealth Technology Develops stem cell storage devices | Health Technology |
BMXP Holdings Shareholders Business Trust | |
JB Clothing Corp.
 JB Clothing Corp. Apparel/Footwear RetailRetail Trade Designs and manufactures women's fashion apparels | Retail Trade |
Regen Biopharma, Inc.
 Regen Biopharma, Inc. BiotechnologyHealth Technology Develops regenerative medicine therapies and tools | Health Technology |
University of California, Riverside
 University of California, Riverside Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BMXP Holdings, Inc.
 BMXP Holdings, Inc. Medical SpecialtiesHealth Technology Develops medical technology and devices for stem cell research | Health Technology |
Rivulet Media, Inc.
 Rivulet Media, Inc. Movies/EntertainmentConsumer Services Engages in production of films | Consumer Services |
Freedom Environmental Services, Inc.
 Freedom Environmental Services, Inc. Miscellaneous Commercial ServicesCommercial Services Provides wastewater and storm water system management services | Commercial Services |
BEFUT International Co. Ltd. /Old/
 BEFUT International Co. Ltd. /Old/ Electrical ProductsProducer Manufacturing Operates a holding company with interest in cable wire production activities in China | Producer Manufacturing |
Entest BioMedical, Inc. /Old/
 Entest BioMedical, Inc. /Old/ Medical SpecialtiesHealth Technology Provides research and development activities relating to stem cell therapies, diabetes testing and medical devices | Health Technology |
Entest Group, Inc.
 Entest Group, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Venture Bridge, Inc. | |
Cell Source Research, Inc. | |
AFN Trust | |
Atlantic International University
 Atlantic International University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zander Therapeutics, Inc.
Zander Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for cancer | Health Technology |
SYBLEU, Inc.
 SYBLEU, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an early-stage company which intends to develop regenerative medical applications | Commercial Services |
Kcl Therapeutics, Inc. | |
BST Partners, Inc. | |
BST Partners, Inc. (Wyoming) |
